ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 780

$1.97M Total Retail Price of All Prescriptions

Rank: 6 out of 780

934 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 934 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

36% of this provider’s 934 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 27,234 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,120 1,449 S3 1 1
OMEPRAZOLE 1,444 1,146 2 3
FUROSEMIDE 1,084 879 3 7
LISINOPRIL 940 729 4 6
LEVOTHYROXINE SODIUM 889 650 5 5
SIMVASTATIN 877 698 6 2
ZOLPIDEM TARTRATE 742 494 7 17
WARFARIN SODIUM 725 612 8 24
METFORMIN HCL 711 496 9 8
GABAPENTIN 633 438 10 13
AMLODIPINE BESYLATE 586 479 11 4
CARVEDILOL 584 522 12 14
SERTRALINE HCL 541 457 13 27
TRAMADOL HCL 470 259 14 15
POTASSIUM CHLORIDE 427 338 15 11
POLYETHYLENE GLYCOL 3350 415 322 16 79
CITALOPRAM HBR 408 299 17 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 393 274 18 26
NEXIUM 389 271 19 22
GLIMEPIRIDE 377 265 20 30
METOPROLOL SUCCINATE 357 317 21 20
ATORVASTATIN CALCIUM 342 247 22 12
MELOXICAM 340 238 23 16
METOPROLOL TARTRATE 322 274 24 19
PRAVASTATIN SODIUM 318 238 25 9
DONEPEZIL HCL 311 295 26 31
NAMENDA 310 308 27 46
CYMBALTA 309 145 28 51
KLOR-CON 10 297 244 29 90
PANTOPRAZOLE SODIUM 287 175 30 25
TRAZODONE HCL 275 198 31 35
LYRICA 270 151 32 52
LOSARTAN POTASSIUM 263 193 33 18
RANITIDINE HCL 262 182 34 39
CHLORTHALIDONE 258 227 35 142
ROPINIROLE HCL 255 189 36 87
SPIRIVA 254 216 37 72
CLOPIDOGREL 252 234 38 34
ATENOLOL 245 142 39 21
ESCITALOPRAM OXALATE 239 185 40 61
PROAIR HFA 238 139 41 62
FENTANYL 232 169 S2 42 107
ALLOPURINOL 221 159 43 29
TAMSULOSIN HCL 216 143 44 36
HYDROCHLOROTHIAZIDE 215 111 45 10
PREDNISONE 184 128 46 40
FLUOXETINE HCL 182 103 47 65
RISPERIDONE 180 135 48 98
MIRTAZAPINE 179 138 49 58
ADVAIR DISKUS 178 127 50 68
JANUVIA 172 124 51 85
OXCARBAZEPINE 169 144 52 276
PLAVIX 169 151 52 45
VERAPAMIL ER 163 147 54 78
TRIAMTERENE-HCTZ 161 142 55 37
LOSARTAN-HYDROCHLOROTHIAZIDE 159 140 56 33
CELEBREX 158 119 57 89
KLOR-CON M20 157 113 58 57
SPIRONOLACTONE 154 114 59 53
FAMOTIDINE 153 142 60 86
DIVALPROEX SODIUM 152 86 61 119
CIPROFLOXACIN HCL 151 127 62 49
AMITRIPTYLINE HCL 150 44 R 63 48
JANTOVEN 150 90 63 295
ESTRADIOL 140 59 R 65 122
FLUTICASONE PROPIONATE 137 76 66 41
TRIAMCINOLONE ACETONIDE 136 116 67 154
PRIMIDONE 134 109 68 199
DILTIAZEM ER 134 121 68 134
PAROXETINE HCL 133 73 70 69
VENLAFAXINE HCL ER 131 85 71 117
LANTUS 130 82 72 71
DIGOXIN 125 104 73 56
INSULIN SYRINGE 120 87 74 80
OLANZAPINE 120 100 74 191
FEXOFENADINE HCL 115 87 76 275
MORPHINE SULFATE ER 115 40 S2 76 141
LOVASTATIN 114 101 78 47
QUETIAPINE FUMARATE 114 74 78 81
DIOVAN 114 110 78 55
BENAZEPRIL HCL 110 88 81 59
CARBAMAZEPINE 109 57 82 257
METHOCARBAMOL 107 28 R 83 84
PROMETHAZINE HCL 104 90 R 84 66
VENTOLIN HFA 103 42 85 91
RAMIPRIL 102 80 86 70
ONDANSETRON HCL 102 64 86 234
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 81 88 88
ISOSORBIDE MONONITRATE ER 99 95 89 60
CYCLOBENZAPRINE HCL 99 32 R 89 42
CRESTOR 98 74 91 32
NABUMETONE 97 64 92 171
LACTULOSE 96 48 93 178
LEVETIRACETAM 94 70 94 130
DIOVAN HCT 92 82 95 75
LIPITOR 91 67 96 175
CARISOPRODOL 90 33 R 97 67
GLIPIZIDE 90 80 97 74
BUSPIRONE HCL 88 53 99 125
FLUCONAZOLE 87 40 100 111
EXELON 86 86 101 132
CLONIDINE HCL 83 50 102 28
ETODOLAC 82 46 103 174
NAPROXEN 81 42 104 100
ZIPRASIDONE HCL 81 64 104 264
PROPRANOLOL HCL 78 39 106 133
NYSTATIN 78 58 106 203
DILTIAZEM 24HR ER 77 65 108 179
AMLODIPINE BESYLATE-BENAZEPRIL 76 39 109 50
DETROL LA 74 39 110 215
ALBUTEROL SULFATE 74 51 110 163
DOXAZOSIN MESYLATE 74 45 110 97
IBUPROFEN 74 34 110 93
CEPHALEXIN 73 52 114 105
MORPHINE SULFATE 73 45 S2 114 258
INDAPAMIDE 72 59 116 190
ABILIFY 72 24 116 197
NOVOLOG 71 46 118 158
QUINAPRIL HCL 70 67 119 113
VESICARE 70 69 119 186
LEXAPRO 69 49 121 219
PEN NEEDLE 67 41 122 136
KLOR-CON M10 67 57 122 168
MECLIZINE HCL 66 56 124 83
HUMULIN 70-30 65 64 125 106
PHENYTOIN SODIUM EXTENDED 65 54 125 128
ACTOS 64 40 127 144
LANTUS SOLOSTAR 63 32 128 121
DIPHENOXYLATE-ATROPINE 61 29 129 250
PRAMIPEXOLE DIHYDROCHLORIDE 61 34 129 156
GEODON 61 52 129 342
AGGRENOX 60 59 132 233
METOCLOPRAMIDE HCL 60 35 132 102
BUPROPION XL 60 49 132 177
AMOX TR-POTASSIUM CLAVULANATE 59 42 135 135
ENDOCET 58 38 S2 136 129
CARBIDOPA-LEVODOPA 58 41 136 124
OXYBUTYNIN CHLORIDE 58 42 136 148
ALENDRONATE SODIUM 57 43 139 44
METFORMIN HCL ER 57 46 139 43
NIFEDICAL XL 57 45 139 209
BACLOFEN 55 21 142 153
RIVASTIGMINE 55 55 142 280
TOPIRAMATE 55 0 142 145
NITROFURANTOIN 55 46 142 235
KLOR-CON 8 55 48 142 194
AZITHROMYCIN 55 46 142 38
SINGULAIR 53 33 148 73
PREMARIN 53 26 R 148 110
AMOXICILLIN 52 36 150 99
HALOPERIDOL 52 50 150 251
FLUOCINONIDE 51 36 152 359
SEROQUEL XR 51 25 152 277
SUMATRIPTAN SUCCINATE 50 30 154 301
RESTASIS 50 50 154 378
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.